IP Library Granted Patent US 8,388,954
Granted Patent B2
US 8,388,954 · App. 10/552,314 · Granted Mar 5, 2013

Stabilising formulation for immunoglobulin G compositions in liquid form and in lyophilised form

Inventors: Annie Bardat (Limours, FR); Edith Begin (Les Ulis, FR); Nassirah Khandoudi (Gif sur Yvette, FR); Olivier Just (Marcoussis, FR); Sami Chtourou (Elancourt, FR); Roland Schmitthaeusler (Montigny le Bretonneux, FR)
Assignee: Laboratoire Francais du Fractionnement et des Biotechnologies
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,388,954
App. No.
10/552,314
Granted
Mar 5, 2013
Kind
B2
Abstract

This invention is related to a stabilizing formulation for immunoglobulins G compositions comprising a sugar alcohol, glycine and a non-ionic detergent, which is suitable for the stabilization of immunoglobulins G compositions in liquid form and in lyophilized form. The invention also relates to an immunoglobulins G composition in liquid form or in lyophilized form comprising said stabilizing formulation.

Claims (6)

1. A stabilizing formulation consisting of mannitol, glycine and a non-ionic detergent, suitable for the stabilisation of an immunoglobulin G composition in liquid form and in lyophilised form, wherein the concentration of mannitol is between 30 g/l and 50 g/l, and wherein the concentration of glycine is between 7 g/1 and 10 g/l.

2. An immunoglobulin G composition in liquid form, consisting of immunoglobulins G, water and the stabilising formulation according to claim 1 .

3. An immunoglobulin G composition in lyophilised form, consisting of immunoglobulins G and the stabilising formulation according to claim 1 .

4. The immunoglobulin G composition according to claim 2 , wherein the composition includes an amount of polymers less than 0.3% after a 6 months storage period at room temperature.

5. The immunoglobulin G composition according to claim 3 , wherein the composition includes an amount of polymers less than 0.3% after a 12 months storage period at room temperature of for 6 months at 40° C.

6. The immunoglobulin G composition according to claim 1 , wherein the composition includes an amount of dimers less than 7% after a 24 months storage period at 4° C.

Assignments (5)
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Apr 3, 2023
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 063237/0439 →
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Sep 21, 2022
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 061493/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2007
From: KOLLET, ORIT; LAPIDOT, TSVEE
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 019447/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2005
From: KOLLET, ORIT; LAPIDOT, TSVEE
To: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Reel/Frame 017135/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2005
From: BARDAT, ANNIE; BEGIN, EDITH; KHANDOUDI, NASSIRAH; JUST, OLIVIER; CHTOUROU, SAMI; SCHMITTHAEUSLER, ROLAND
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 016896/0721 →
Priority Claims (1)
FR 03 04388 · Apr 9, 2003 · national
Continuity (1)
Related Publication 20070036779A1 · Feb 15, 2007